Form 4: Supernus Pharmaceuticals Executive Exercises Options and Sells Shares
SEC Form 4 Filing
Padmanabh P. Bhatt, Sr. VP of IP and CSO at Supernus Pharmaceuticals, exercised stock options and sold shares on February 4, 2025.
Summary
- On February 4, 2025, Padmanabh P. Bhatt, Sr. VP of IP and CSO at Supernus Pharmaceuticals, exercised employee stock options to acquire 9,477 shares of common stock at a price of $29.61 per share.
- Simultaneously, Bhatt sold 9,477 shares of common stock at a weighted average price of $39.7, with individual sales ranging from $39.61 to $39.90.
- Following these transactions, Bhatt directly owns 10,149 shares of Supernus Pharmaceuticals common stock.
- Bhatt also holds options for 4,250 shares.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing an executive's stock transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information.
Positives
- The exercise of options and subsequent sale of shares indicates that the executive believes the shares are fairly valued.
Industry Context
Form 4 filings are a routine part of the US stock market and are required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors as they can provide insights into management's views on the company's stock.
Comparison to Industry Standards
- Executive compensation packages often include stock options to align management's interests with those of shareholders.
- The vesting schedule of the options (four equal installments beginning on February 19, 2022) is a common practice.
- The sale of shares after exercising options is a typical way for executives to realize the value of their compensation.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it involves a relatively small number of shares.
- The executive's actions may be interpreted as a sign of confidence in the company, but it could also be for personal financial planning.
Key Dates
| Date | Description |
|---|---|
| 02/19/2022 | Option vesting began in four equal installments. |
| 02/04/2025 | Date of transaction: Exercise of stock options and sale of shares. |
| 02/05/2025 | Date of signature on the Form 4 filing. |
| 02/19/2031 | Expiration date of the employee stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.